首页> 外文期刊>Toxicology and Applied Pharmacology >Diallyl sulfide inhibition of CYP2E1 does not rescue diabetic rats from thioacetamide-induced mortality.
【24h】

Diallyl sulfide inhibition of CYP2E1 does not rescue diabetic rats from thioacetamide-induced mortality.

机译:对CYP2E1的二烯丙基硫醚的抑制不能使硫代乙酰胺诱发的死亡挽救糖尿病大鼠。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Previously we have shown that hepatotoxicity of thioacetamide (TA) was increased in streptozotocin (STZ)-induced diabetic (DB) rats due to combined effects of enhanced bioactivation-based liver injury of TA and compromised liver tissue repair response. We have also shown that TA is primarily bioactivated by hepatic CYP2E1. The present study was done to further investigate the importance of liver tissue repair in determining the final outcome of hepatotoxicity. STZ-induced DB rats were pretreated with a CYP2E1 inhibitor, diallyl sulfide (DAS), to decrease the bioactivation-based liver injury of TA. The treatments were as follows: DB/DAS/TA, DB/corn oil/TA, and DB/DAS/saline. Nondiabetic (non-DB) rats received the same treatments as controls. A dose of TA (300 mg/kg ip), which was nonlethal in non-DB rats, caused 92 and 90% mortality in DB/DAS/TA and DB/corn oil/TA groups, respectively. At various times (0--60 h) after treatment, liver injury was assessed by plasma alanine aminotransferase and histopathology. Cell proliferation was evaluated by [(3)H]thymidine incorporation and immunohistochemical staining of proliferating cell nuclear antigen (PCNA). In the DB/DAS/TA rats, DAS pretreatment markedly reduced the CYP2E1-dependent liver injury of TA compared to that in DB/corn oil/TA rats. However, subsequent hepatic DNA synthesis in both DB groups was inhibited approximately 50%. PCNA analysis showed a corresponding decrease in cell-cycle progression. This compromised tissue repair response in DB rats was insufficient to compensate for cell loss, resulting in progression of liver injury and culminating in high mortality in both DB groups. Furthermore, non-DB rats were pretreated with a CYP2E1 inducer, isoniazid, to increase the bioactivation-based TA liver injury equal to the liver injury observed in DB/DAS/TA rats. Despite equal injury up to 36 h following TA treatment, the tissue repair response in the non-DB rats was highly stimulated to compensate for liver injury and led to 70% survival in this group. These studies underscore the importance of adequate and timely tissue repair in compensating for liver injury and protecting from lethality. Copyright 2001 Academic Press.
机译:以前我们已经表明,链脲佐菌素(STZ)诱导的糖尿病(DB)大鼠的硫代乙酰胺(TA)的肝毒性由于增强的基于TA的生物活化性肝损伤和受损的肝组织修复反应的综合作用而增加。我们还显示,TA主要被肝CYP2E1生物激活。进行本研究以进一步调查肝组织修复在确定肝毒性最终结果中的重要性。用CYP2E1抑制剂二烯丙基硫醚(DAS)预处理STZ诱导的DB大鼠,以减少TA的基于生物激活的肝损伤。处理方法如下:DB / DAS / TA,DB /玉米油/ TA和DB / DAS /盐水。非糖尿病(non-DB)大鼠接受与对照组相同的治疗。在非DB大鼠中非致命性的TA剂量(300 mg / kg ip)在DB / DAS / TA和DB /玉米油/ TA组中分别导致92%和90%的死亡率。在治疗后的不同时间(0--60小时),通过血浆丙氨酸氨基转移酶和组织病理学评估肝损伤。通过[(3)H]胸苷掺入和增殖细胞核抗原(PCNA)的免疫组织化学染色评估细胞增殖。在DB / DAS / TA大鼠中,与DB /玉米油/ TA大鼠相比,DAS预处理显着降低了CYP2E1依赖性肝损伤。然而,随后在两个DB组中的肝DNA合成被抑制约50%。 PCNA分析显示细胞周期进程相应减少。 DB大鼠中受损的组织修复反应不足以补偿细胞损失,导致肝损伤的进展并最终导致两个DB组的高死亡率。此外,非DB大鼠用CYP2E1诱导剂异烟肼预处理,以增加基于生物激活的TA​​肝损伤,与在DB / DAS / TA大鼠中观察到的肝损伤相同。尽管在TA治疗后长达36小时有相同的损伤,但非DB大鼠的组织修复反应受到了强烈刺激,以补偿肝损伤,并导致该组的存活率达到70%。这些研究强调了及时适当的组织修复在补偿肝损伤和防止致死性方面的重要性。版权所有2001学术出版社。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号